Option Care Health (NASDAQ:OPCH) Sees Strong Trading Volume – Time to Buy?

Option Care Health, Inc. (NASDAQ:OPCH) shares saw unusually-strong trading volume on Wednesday. Approximately 2,914,495 shares traded hands during mid-day trading, an increase of 5% from the previous session’s volume of 2,766,312 shares. The stock last traded at $31.0050 and had previously closed at $31.00.

Option Care Health News Summary

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: CD&R and McKesson agreed to acquire Option Care Health for $32.05 per share in cash, representing a 37% premium to the prior closing price and an implied enterprise value of approximately $5.8 billion. The transaction provides shareholders with a defined cash exit and was the primary catalyst for the stock’s surge. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: Unusually heavy call-option activity—5,219 contracts purchased versus typical daily volume of 281—signals elevated speculative interest following the buyout announcement, although it does not guarantee further gains.
• Neutral Sentiment: Citizens JMP and Barrington Research both reaffirmed “Market Perform” ratings. These ratings are less relevant after the proposed take-private transaction but indicate neither firm issued a stronger bullish view. Option Care Health Stock Rating Reaffirmed
• Neutral Sentiment: Recent operating results were solid, with quarterly EPS of $0.45 exceeding the $0.43 consensus estimate and revenue of $1.44 billion topping expectations. However, the buyout terms now matter more to investors than standalone earnings prospects.
• Negative Sentiment: Shares remain below the $32.05 offer price, creating a deal spread that reflects potential risks involving regulatory approval, shareholder approval, financing, or failure to close. Option Care Stock Trades Below McKesson’s Deal Price
• Negative Sentiment: Several investor-rights law firms are investigating whether the $32.05 price fairly values Option Care Health and whether insiders received benefits unavailable to public shareholders. Such reviews could create litigation, delays, or pressure to improve the offer, though they do not necessarily indicate wrongdoing. Ademi LLP Option Care Health Shareholder Alert

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Zacks Research upgraded Option Care Health from a “strong sell” rating to a “hold” rating in a research report on Monday, July 6th. William Blair lowered Option Care Health to a “market perform” rating in a research report on Tuesday. UBS Group reissued a “buy” rating on shares of Option Care Health in a report on Tuesday, September 22nd. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and increased their price objective for the stock from $28.00 to $32.05 in a report on Tuesday. Finally, Weiss Ratings raised Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Four analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $29.70.

Option Care Health Stock Performance

The firm’s 50-day simple moving average is $23.78 and its two-hundred day simple moving average is $23.55. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $4.65 billion, a PE ratio of 23.35, a PEG ratio of 1.35 and a beta of 0.58.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The firm had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.42 billion. During the same quarter last year, the firm earned $0.41 earnings per share. The business’s revenue for the quarter was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, equities research analysts expect that Option Care Health, Inc. will post 1.7 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors have recently added to or reduced their stakes in the stock. Harbor Investment Advisory LLC acquired a new stake in Option Care Health in the 2nd quarter valued at $48,000. Nykredit A S acquired a new position in Option Care Health during the second quarter worth $56,000. Public Employees Retirement System of Ohio bought a new position in shares of Option Care Health during the second quarter valued at $66,000. KBC Group NV lifted its holdings in shares of Option Care Health by 22.1% during the first quarter. KBC Group NV now owns 5,453 shares of the company’s stock valued at $147,000 after acquiring an additional 988 shares during the period. Finally, Summitry LLC acquired a new stake in shares of Option Care Health in the 1st quarter valued at $200,000. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.